FBIO
Companies
NASDAQ
Fortress Biotech Inc.
Health Care
$1.81
-$0.22 (-10.84%)
Price Chart
Overview
About FBIO
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.
Market Cap
$35.8M
Volume
281.5K
Avg. Volume
313.1K
P/E Ratio
-1.0284091
Dividend Yield
0.00%
Employees
112.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.62
High Correlation
Volatility
High (0.81)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, FBIO shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$35.8M
Volume281.5K
P/E Ratio-1.03
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
April 1, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025